Recently, the death of a 2-year-old boy following an intravenous infusion has drawn widespread public attention. According to an official statement from local authorities, the child visited a primary healthcare facility due to symptoms including fever and cough. Diagnosed with an upper respiratory tract infection, he was given an IV infusion. During the procedure, he suddenly experienced respiratory distress and lost consciousness; despite emergency resuscitation efforts, he passed away.Local health authorities have launched an investigation. Preliminary findings rule out intentional medical misconduct, but the exact cause of death awaits autopsy results and expert evaluation.This tragic incident has reignited public concerns over pediatric medication safety, standards in primary healthcare, and the risks associated with unnecessary IV infusions. Medical experts emphasize that infants and young children have immature physiological systems and are highly sensitive to medications. Intravenous therapy is not a universal solution and should only be used when strictly indicated. China’s National Health Commission has long advocated the principle: ‘Oral administration over injection, injection over IV infusion,’ especially in pediatric care.The clinic involved has temporarily suspended related services. The child’s family is cooperating with the ongoing investigation. Authorities pledged to handle the case in accordance with laws and regulations and to enhance training and oversight of frontline medical personnel to prevent similar tragedies.
近日，一则关于‘2岁男童输液后死亡’的事件引发社会广泛关注。据当地官方通报，该男童因发热、咳嗽等症状前往某基层医疗机构就诊，医生诊断为上呼吸道感染，并给予静脉输液治疗。输液过程中，患儿突发呼吸困难、意识丧失，经抢救无效不幸离世。目前，当地卫健部门已介入调查，初步排除医疗故意行为，具体死因需等待尸检和专家鉴定结果。此事件再次引发公众对儿童用药安全、基层医疗规范及输液风险的关注。医学专家指出，婴幼儿身体机能尚未发育完全，对药物反应敏感，输液并非‘万能疗法’，应严格掌握适应症。国家卫健委早已倡导‘能口服不注射，能注射不输液’的用药原则，尤其在儿科诊疗中更应谨慎。目前，涉事医疗机构已暂停相关诊疗活动，家属情绪稳定，正配合后续调查。相关部门表示将依法依规处理，并加强基层医务人员培训与监管，防止类似悲剧重演。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/2828.html